You are here: Industry Insights > Results

News List

InnoCare Releases 2023 Results and Business Highlights PharmaSources
March 29, 2024
InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023.
WuXi Biologics Achieved Remarkable Results in 2019 Wuxi Biologics
March 27, 2020
WuXi Biologics Achieved Remarkable Results in 2019, and is working to defeat COVID-19.
Sun Pharma reports Q1FY20 results expresspharma
August 15, 2019
Sun Pharmaceutical Industries has announced its Q1FY20 results, reporting a surge of 16 per sent in its gross sales which stood at Rs.8,259 crores. The net profit also witnessed a hike of 31 per cent at Rs 1387 crores.
GC Pharma Reports Q2 2019 Results prnasia
August 06, 2019
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended June 30, 2019.
Janssen Reports Positive Top-Line Phase 3 Results for Ponesimod americanpharmaceuticalreview
July 29, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced positive top-line results from the Phase 3 OPTIMUM study, which evaluated the efficacy and safety of ponesimod compared to Aubagio® (teriflunomide) in adults with ...
Syngene announces Q1 FY20 results expresspharma
July 26, 2019
Syngene International has announced its Q1 FY20 results, wherein the company posted quarterly revenue of Rs 441 crores, an increase of four per cent from the corresponding quarter last year.
New opioid with faster results and less side effects developed pharmaceutical-technology
May 23, 2019
Researchers at Tulane University, US, have developed a new opioid that works quicker than morphine and other opioid painkillers, and does not produce the same pain sensitivity and addiction.
Penn presents positive results for targeted leukaemia drug pharmpacpeutical-technology
April 03, 2019
Researchers from the University of Pennsylvania (Penn) Abramson Cancer Center have announced findings from the ADMIRAL trial of gilteritinib in patients with relapsed or refractory acute myeloid leukaemia (AML) with a mutation in the Fms-like tyrosine kin
WuXi Biologics Continues to Deliver Record Results en-cphi.cn
March 19, 2019
WuXi Biologics announces its audited annual results for the year ended December 31, 2018 today.
J&J reports 2018 fourth-quarter results biospectrumasia
January 24, 2019
Worldwide sales for the full-year 2018 were $81.6 billion, an increase of 6.7% versus 2017

Previous page 1 2 3 Next page